News The first step for a medicinal product for vitiligo has been authorized in Europe On February 23, 2023, the European Medicines Agency (EMA) published a positive opinion for the…VIPOC3 March 2023
Vitiligo research Current Status of Cell-Based Therapies for Vitiligo Abstract Vitiligo is a chronic pigmentary disease with complex etiology, the signs of which are…VIPOC23 February 2023
Sun Protection and Vitiligo Types of Sun Protective Clothing It's important for vitiligo patients to protect their skin from the sun's harmful UV rays.…VIPOC23 February 2023
Sun Protection and Vitiligo Protecting Against UVA Rays in the Car People with vitiligo may be concerned about protecting their skin from the sun while driving…VIPOC23 February 2023
Events Good news from the Franco-Congolese Vitiligo Association our newest VIPOC member With a lot of energy and willpower, The President, Huguette Kalenga Fabiola, and the…VIPOC1 February 2023
Vitiligo research Vitiligo in Children: A Review of Conventional Treatments Introduction Vitiligo is an acquired, chronic, maybe autoimmune, pigmentary disorder characterised by white macules and…VIPOC25 January 2023
Vitiligo research Assessing Behavioral and Psychological Symptoms in Chinese Vitiligo Patients Background: Vitiligo is a common, acquired depigmenting disorder. The pathogenesis is not clear, neuropsychological factors may…VIPOC20 January 2023
Events The Vitiligo International Symposium 2022 The Vitiligo International Symposium (VIS) was held from December 9th to 11th in Bangalore (India),…VIPOC13 January 2023
Vitiligo research Approaching Nonsegmental Vitiligo with a Focus on the Immune-Mediated Aspects of the Disease and a New Treatment Option to Consider Managing vitiligo has been a challenging journey. There have been limited options available for dermatologists…VIPOC4 January 2023
Vitiligo research The Genetic Basis of Vitiligo Vitiligo is a complex disease in which autoimmune destruction of epidermal melanocytes results inpatches of…VIPOC2 December 2022